
TY  - JOUR
TI  - Poster Session 3
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 21
IS  - S15
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.21248
DO  - doi:10.1002/mds.21248
SP  - S517
EP  - S613
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts of the 2012 PNS/Inflammatory Neuropathy Consortium Meeting June 24–27, 2012 Rotterdam, The Netherlands
JO  - Journal of the Peripheral Nervous System
VL  - 17
IS  - 2
SN  - 1085-9489
UR  - https://doi.org/10.1111/j.1529-8027.2012.00410.x
DO  - doi:10.1111/j.1529-8027.2012.00410.x
SP  - 229
EP  - 282
PY  - 2012
ER  - 

TY  - JOUR
TI  - 2017 Peripheral Nerve Society Meeting July 8–12, 2017 Sitges, Barcelona, Spain
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 22
IS  - 3
SN  - 1085-9489
UR  - https://doi.org/10.1111/jns.12225
DO  - doi:10.1111/jns.12225
SP  - 226
EP  - 414
PY  - 2017
ER  - 

TY  - JOUR
TI  - Contributed Poster Presentations
JO  - Value in Health
VL  - 8
IS  - 6
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2005.00063.x
DO  - doi:10.1111/j.1524-4733.2005.00063.x
SP  - A23
EP  - A220
PY  - 2005
ER  - 

TY  - JOUR
AU  - Riemann, Dieter
AU  - Baglioni, Chiara
AU  - Bassetti, Claudio
AU  - Bjorvatn, Bjørn
AU  - Dolenc Groselj, Leja
AU  - Ellis, Jason G.
AU  - Espie, Colin A.
AU  - Garcia-Borreguero, Diego
AU  - Gjerstad, Michaela
AU  - Gonçalves, Marta
AU  - Hertenstein, Elisabeth
AU  - Jansson-Fröjmark, Markus
AU  - Jennum, Poul J.
AU  - Leger, Damien
AU  - Nissen, Christoph
AU  - Parrino, Liborio
AU  - Paunio, Tiina
AU  - Pevernagie, Dirk
AU  - Verbraecken, Johan
AU  - Weeß, Hans-Günter
AU  - Wichniak, Adam
AU  - Zavalko, Irina
AU  - Arnardottir, Erna S.
AU  - Deleanu, Oana-Claudia
AU  - Strazisar, Barbara
AU  - Zoetmulder, Marielle
AU  - Spiegelhalder, Kai
TI  - European guideline for the diagnosis and treatment of insomnia
JO  - Journal of Sleep Research
JA  - J Sleep Res
VL  - 26
IS  - 6
SN  - 0962-1105
UR  - https://doi.org/10.1111/jsr.12594
DO  - doi:10.1111/jsr.12594
SP  - 675
EP  - 700
KW  - evidence-based medicine
KW  - CBT-I
KW  - hypnotics
PY  - 2017
AB  - Summary This European guideline for the diagnosis and treatment of insomnia was developed by a task force of the European Sleep Research Society, with the aim of providing clinical recommendations for the management of adult patients with insomnia. The guideline is based on a systematic review of relevant meta-analyses published till June 2016. The target audience for this guideline includes all clinicians involved in the management of insomnia, and the target patient population includes adults with chronic insomnia disorder. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) system was used to grade the evidence and guide recommendations. The diagnostic procedure for insomnia, and its co-morbidities, should include a clinical interview consisting of a sleep history (sleep habits, sleep environment, work schedules, circadian factors), the use of sleep questionnaires and sleep diaries, questions about somatic and mental health, a physical examination and additional measures if indicated (i.e. blood tests, electrocardiogram, electroencephalogram; strong recommendation, moderate- to high-quality evidence). Polysomnography can be used to evaluate other sleep disorders if suspected (i.e. periodic limb movement disorder, sleep-related breathing disorders), in treatment-resistant insomnia, for professional at-risk populations and when substantial sleep state misperception is suspected (strong recommendation, high-quality evidence). Cognitive behavioural therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age (strong recommendation, high-quality evidence). A pharmacological intervention can be offered if cognitive behavioural therapy for insomnia is not sufficiently effective or not available. Benzodiazepines, benzodiazepine receptor agonists and some antidepressants are effective in the short-term treatment of insomnia (≤4 weeks; weak recommendation, moderate-quality evidence). Antihistamines, antipsychotics, melatonin and phytotherapeutics are not recommended for insomnia treatment (strong to weak recommendations, low- to very-low-quality evidence). Light therapy and exercise need to be further evaluated to judge their usefulness in the treatment of insomnia (weak recommendation, low-quality evidence). Complementary and alternative treatments (e.g. homeopathy, acupuncture) are not recommended for insomnia treatment (weak recommendation, very-low-quality evidence).
ER  - 

TY  - JOUR
TI  - TSANZ Poster Abstracts
JO  - Respirology
JA  - Respirology
VL  - 18
IS  - S2
SN  - 1323-7799
UR  - https://doi.org/10.1111/resp.12046
DO  - doi:10.1111/resp.12046
SP  - 38
EP  - 85
PY  - 2013
ER  - 

TY  - JOUR
TI  - 49th ANNUAL MEETING
JO  - Medical Physics
JA  - Med. Phys.
VL  - 34
IS  - 6Part24
SN  - 0094-2405
UR  - https://doi.org/10.1002/j.2473-4209.2007.tb00534.x
DO  - doi:10.1002/j.2473-4209.2007.tb00534.x
SP  - 2261
EP  - 2672
PY  - 2007
ER  - 

TY  - JOUR
TI  - Contents
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 30
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-007-9987-1
DO  - doi:10.1007/s10545-007-9987-1
SP  - 1
EP  - 178
PY  - 2007
ER  - 

TY  - JOUR
TI  - THE AUSTRALASIAN SOCIETY FOR INFECTIOUS DISEASES
JO  - Australian and New Zealand Journal of Medicine
VL  - 29
IS  - 4
SN  - 0004-8291
UR  - https://doi.org/10.1111/j.1445-5994.1999.tb00773.x
DO  - doi:10.1111/j.1445-5994.1999.tb00773.x
SP  - 601
EP  - 625
PY  - 1999
ER  - 

TY  - JOUR
TI  - Tuesday, 1 September 2009 - Parallel Sessions 19-36
JO  - Transplant International
VL  - 22
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2009.00960.x
DO  - doi:10.1111/j.1432-2277.2009.00960.x
SP  - 45
EP  - 81
PY  - 2009
ER  - 

TY  - JOUR
TI  - Clinical Nutrition Week–Nutrition Practice Posters 2009
JO  - Nutrition in Clinical Practice
JA  - Nutr Clin Pract
VL  - 24
IS  - 1
SN  - 0884-5336
UR  - https://doi.org/10.1177/0884533608330079
DO  - doi:10.1177/0884533608330079
SP  - 110
EP  - 165
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts Oral Presentations – Educational Day
JO  - Clinical & Experimental Immunology
VL  - 154
IS  - s1
SN  - 0009-9104
UR  - https://doi.org/10.1111/j.1365-2249.2008.03767.x
DO  - doi:10.1111/j.1365-2249.2008.03767.x
SP  - 1
EP  - 224
PY  - 2008
ER  - 

TY  - JOUR
TI  - AAPM 2012 ANNUAL MEETING ABSTRACTS
JO  - Pain Medicine
VL  - 13
IS  - 2
SN  - 1526-2375
UR  - https://doi.org/10.1111/j.1526-4637.2012.01331.x
DO  - doi:10.1111/j.1526-4637.2012.01331.x
SP  - 281
EP  - 349
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts for the Annual Scientific Meeting of the Thoracic Society of Australia & New Zealand ‘Maintaining Lung Health from Cradle to Grave’ 7–12 April 2000, Melbourne, Australia
JO  - Respirology
VL  - 5
IS  - S1
SN  - 1323-7799
UR  - https://doi.org/10.1111/resp.2000.5.s1.a1
DO  - doi:10.1111/resp.2000.5.s1.a1
SP  - A1
EP  - A73
PY  - 2000
ER  - 

TY  - JOUR
TI  - ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 20
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.1996.tb01181.x
DO  - doi:10.1111/j.1530-0277.1996.tb01181.x
SP  - 4A
EP  - 147A
PY  - 1996
ER  - 

TY  - JOUR
TI  - International Society of Pediatric Oncology SIOP XXVIII Meeting Vienna, Austria, October 1-5, 1996 : Abstracts
JO  - Medical and Pediatric Oncology
JA  - Med. Pediatr. Oncol.
VL  - 27
IS  - 4
SN  - 0098-1532
UR  - https://doi.org/10.1002/(SICI)1096-911X(199610)27:4<209::AID-MPO1>3.0.CO;2-R
DO  - doi:10.1002/(SICI)1096-911X(199610)27:4<209::AID-MPO1>3.0.CO;2-R
SP  - 209
EP  - 374
PY  - 1996
ER  - 

TY  - JOUR
TI  - Posters
JO  - Diabetic Medicine
VL  - 19
IS  - s2
SN  - 0742-3071
UR  - https://doi.org/10.1046/j.1464-5491.19.s2.7.x
DO  - doi:10.1046/j.1464-5491.19.s2.7.x
SP  - 28
EP  - 115
PY  - 2002
ER  - 

C7  - pp. 489-501
TI  - Index
SN  - 9780470066485
UR  - https://doi.org/10.1002/9780470713990.index
DO  - doi:10.1002/9780470713990.index
SP  - 489-501
PY  - 2002
ER  - 

TY  - JOUR
AU  - Sunderkötter, Cord
AU  - Herrmann, Mathias
AU  - Jappe, Uta
TI  - Antimicrobial therapy in Dermatology
JO  - JDDG: Journal der Deutschen Dermatologischen Gesellschaft
VL  - 4
IS  - 1
SN  - 9780470066485
UR  - https://doi.org/10.1111/j.1610-0387.2006.05901.x
DO  - doi:10.1111/j.1610-0387.2006.05901.x
SP  - 10
EP  - 27
KW  - antibiotics
KW  - antiseptics
KW  - β-lactam resistance
KW  - soft tissue infection
KW  - Antiseptika
KW  - Antibiotika
KW  - β-Laktam-Resistenz
KW  - Weichteilinfektion
PY  - 2006
AB  - Summary The extensive and sometimes indiscriminate use of antibiotics sometimes without strict indications has led to increases in both bacterial resistance and sensitization of patients. Systemic antibiotics in skin infections are indicated when a severe local infection occurs which spreads into the surrounding tissue or when there are signs of systemic infection. There are special indications in patients with peripheral arterial occlusive disease,diabetes or immunosuppression. Topical use of antibiotics should be abandoned and replaced by antiseptics. The ?-lactam antibiotics are the antibiotics of first choice for many skin infections. They are usually effective, have a well-defined profile of adverse events and most are affordable. Penicillin G or V are the first line treatment for erysipelas. Infections with Staphylococcus aureus are usually treated with isoxazolyl penicillins or second generation cephalosporins. In mixed infections in patients with diabetes or peripheral arterial occlusive disease,the treatment of choice is metronidazole plus ?-lactam-/?-lactamase inhibitor antibiotics, but quinolones or second generation cephalosporins can also be used, once again with metronidazole. The aim of this review is to define the indications for antibiotics in dermatology, to highlight their modes of action and adverse effects and to make suggestions for rational antibiotic therapy in cutaneous infections frequently encountered in the practice of dermatology.
ER  - 

TY  - JOUR
TI  - Short Communications
JO  - European Journal of Neurology
VL  - 17
IS  - s3
SN  - 9780470066485
UR  - https://doi.org/10.1111/j.1468-1331.2010.03231.x
DO  - doi:10.1111/j.1468-1331.2010.03231.x
SP  - 20
EP  - 71
PY  - 2010
ER  - 
